A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Body composition is the proportion of fat mass to fat-free mass (muscle, bone, water, organs). Adipose tissue is not merely a storage depot but an endocrine organ secreting adipokines including leptin (which signals satiety to the hypothalamus) and adiponectin (which improves insulin sensitivity). The hypothalamic regulation of food intake integrates hormonal signals from adipose tissue (leptin), the gut (ghrelin, GLP-1, PYY), and the pancreas (insulin) to maintain energy homeostasis around a defended body weight set point. Long-term weight loss is resisted by compensatory reductions in BMR and increased appetite signaling.
Trace the hormonal feedback loop from adipose tissue to hypothalamus to food intake behavior. Compare body composition assessment methods (DEXA, hydrostatic weighing, bioelectrical impedance, BMI) and understand why they give different results.
The energy balance equation is deceptively simple: energy stored equals energy consumed minus energy expended. When more calories enter than leave, body mass increases; when less enters than leaves, it decreases. You already know from energy metabolism that the body's fuel currency is ATP and that macronutrients differ in caloric density (carbohydrates and protein at ~4 kcal/g, fat at ~9 kcal/g). But the energy balance framework hides enormous biological complexity — particularly the body's active, hormonal defense of a body weight set point that resists deviation in both directions.
Body composition is the partitioning of total body mass into fat mass and fat-free mass. Fat-free mass includes skeletal muscle, bone, organs, and body water. This distinction matters clinically and metabolically: two people at identical body weight and height can have dramatically different health profiles. Lean mass is metabolically active — skeletal muscle consumes significant energy at rest and responds to insulin to take up glucose. The location of fat also matters: visceral adipose tissue (surrounding abdominal organs) is more metabolically dangerous than subcutaneous fat, more strongly associated with insulin resistance, dyslipidemia, and cardiovascular risk. Measuring body composition accurately requires DEXA (dual-energy X-ray absorptiometry), hydrostatic weighing, or air displacement plethysmography; BMI is a population-level proxy that misclassifies a substantial fraction of individuals.
You know from endocrine physiology that adipose tissue is an endocrine organ. Its primary signal is leptin, a peptide hormone secreted in proportion to total fat mass. Leptin travels to the hypothalamus and binds receptors in the arcuate nucleus, suppressing orexigenic (appetite-stimulating) neurons (NPY/AgRP) and activating anorexigenic (appetite-suppressing) neurons (POMC/CART). In a person with adequate fat stores, high leptin chronically suppresses appetite and nudges energy expenditure upward. When fat mass drops — as in sustained caloric restriction — leptin falls sharply, the hypothalamus interprets this as a starvation signal, appetite increases dramatically, and basal metabolic rate decreases through reduced thyroid hormone and sympathetic tone. This is the physiological basis for the weight loss plateau and rebound: the body actively fights to restore its defended set point, and the resistance intensifies the further weight drops from baseline.
Ghrelin, secreted by the stomach, acts as a short-term hunger signal — it rises sharply before meals and falls after eating. In people who have lost significant weight, ghrelin levels are chronically elevated compared to people who have always been at that lower weight, further amplifying appetite. Insulin signals energy abundance and promotes fat and glycogen storage; chronically elevated insulin (as in insulin resistance) promotes adipogenesis. Together, these signals form a redundant, multi-layered homeostatic system that evolved to prevent starvation — which was the dominant nutritional threat throughout human evolutionary history. This framework explains why behavioral interventions alone produce modest long-term weight loss, why pharmacological and surgical interventions targeting the hormonal system can be more effective, and why the "willpower" framing of obesity misconceives it as a moral failure rather than a physiological disorder of set-point defense.